Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Virus Replication | 9 | 2016 | 2534 | 0.910 |
Why?
|
| Mycobacterium tuberculosis | 6 | 2016 | 1832 | 0.830 |
Why?
|
| HIV-1 | 14 | 2012 | 6939 | 0.660 |
Why?
|
| Antigens, Differentiation | 2 | 2016 | 927 | 0.450 |
Why?
|
| Monocytes | 3 | 2022 | 2596 | 0.420 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 592 | 0.320 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 72 | 0.290 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1903 | 0.280 |
Why?
|
| Gene Products, tat | 1 | 2006 | 120 | 0.270 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2020 | 4420 | 0.270 |
Why?
|
| Simian immunodeficiency virus | 4 | 2001 | 846 | 0.260 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3690 | 0.230 |
Why?
|
| Tuberculosis | 2 | 2012 | 1912 | 0.210 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2006 | 635 | 0.200 |
Why?
|
| Transcription Factors | 4 | 2012 | 12208 | 0.200 |
Why?
|
| Lymphotoxin-alpha | 1 | 2020 | 96 | 0.190 |
Why?
|
| HIV-2 | 1 | 2000 | 167 | 0.180 |
Why?
|
| Receptors, IgG | 1 | 2022 | 582 | 0.160 |
Why?
|
| RNA Interference | 2 | 2006 | 2889 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7880 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2020 | 4386 | 0.160 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1200 | 0.160 |
Why?
|
| Antigens, Bacterial | 1 | 2004 | 1171 | 0.160 |
Why?
|
| Reassortant Viruses | 1 | 1997 | 37 | 0.150 |
Why?
|
| Immunologic Memory | 1 | 2004 | 1348 | 0.150 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 12072 | 0.140 |
Why?
|
| Gene Products, gag | 1 | 1997 | 337 | 0.140 |
Why?
|
| Image Cytometry | 1 | 2016 | 54 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2006 | 2924 | 0.140 |
Why?
|
| Toxoplasma | 1 | 2016 | 150 | 0.130 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2006 | 2232 | 0.130 |
Why?
|
| HIV Infections | 7 | 2016 | 16718 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2015 | 19229 | 0.130 |
Why?
|
| Exodeoxyribonucleases | 1 | 2016 | 180 | 0.130 |
Why?
|
| Hydrogen Peroxide | 2 | 1996 | 731 | 0.130 |
Why?
|
| Macrophages | 3 | 2016 | 5655 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2020 | 1836 | 0.120 |
Why?
|
| Interferon-beta | 1 | 2016 | 323 | 0.120 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 1997 | 952 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2015 | 23403 | 0.110 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 354 | 0.110 |
Why?
|
| Phagocytosis | 2 | 2016 | 1539 | 0.110 |
Why?
|
| Endosomes | 1 | 2015 | 520 | 0.110 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2012 | 38 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 565 | 0.100 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2012 | 78 | 0.100 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2011 | 88 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1655 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 5867 | 0.100 |
Why?
|
| Jurkat Cells | 2 | 2006 | 743 | 0.090 |
Why?
|
| Acetylation | 2 | 2020 | 1085 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2004 | 4479 | 0.090 |
Why?
|
| Protein Transport | 1 | 2015 | 1988 | 0.090 |
Why?
|
| Reactive Oxygen Species | 2 | 1996 | 2077 | 0.080 |
Why?
|
| Transcription, Genetic | 4 | 2020 | 7722 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 300 | 0.080 |
Why?
|
| Cell Line | 7 | 2006 | 15997 | 0.080 |
Why?
|
| DNA, Single-Stranded | 1 | 1990 | 354 | 0.080 |
Why?
|
| Anti-HIV Agents | 1 | 2004 | 4256 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 571 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1477 | 0.080 |
Why?
|
| Gene Expression | 1 | 2020 | 7799 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2440 | 0.070 |
Why?
|
| Genes, env | 2 | 1997 | 95 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 1990 | 558 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 3505 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4204 | 0.070 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 127 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2006 | 3128 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5974 | 0.070 |
Why?
|
| DNA Damage | 2 | 1993 | 2432 | 0.070 |
Why?
|
| Chimera | 2 | 2016 | 485 | 0.070 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 147 | 0.060 |
Why?
|
| Species Specificity | 1 | 2009 | 2478 | 0.060 |
Why?
|
| Biological Transport | 1 | 2009 | 2118 | 0.060 |
Why?
|
| Tuberculin | 1 | 2004 | 66 | 0.060 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 336 | 0.060 |
Why?
|
| Clonal Anergy | 1 | 2004 | 169 | 0.060 |
Why?
|
| DNA, Viral | 3 | 2006 | 2225 | 0.060 |
Why?
|
| Histones | 2 | 2020 | 2599 | 0.060 |
Why?
|
| Genes, gag | 2 | 2005 | 61 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 10638 | 0.050 |
Why?
|
| Software | 1 | 2016 | 4443 | 0.050 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 130 | 0.050 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2022 | 70 | 0.050 |
Why?
|
| Protein Binding | 2 | 2020 | 9386 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2022 | 224 | 0.050 |
Why?
|
| Conserved Sequence | 2 | 2020 | 1202 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2006 | 13815 | 0.050 |
Why?
|
| Monkey Diseases | 1 | 2000 | 77 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2009 | 2969 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2012 | 2958 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 18111 | 0.040 |
Why?
|
| Gene Products, env | 2 | 1997 | 263 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2009 | 3200 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3846 | 0.040 |
Why?
|
| Superoxide Dismutase | 2 | 1993 | 597 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2020 | 13033 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 5524 | 0.040 |
Why?
|
| Humans | 20 | 2022 | 744343 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2000 | 915 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2004 | 810 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1950 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2022 | 495 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 2000 | 2375 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 551 | 0.030 |
Why?
|
| Cell Division | 1 | 2004 | 4568 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2000 | 570 | 0.030 |
Why?
|
| Base Sequence | 3 | 2016 | 12797 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2006 | 6544 | 0.030 |
Why?
|
| Burundi | 1 | 1995 | 17 | 0.030 |
Why?
|
| Macaca | 1 | 1997 | 440 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2006 | 5456 | 0.030 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 1997 | 314 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 3772 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 3462 | 0.030 |
Why?
|
| Vagina | 2 | 2016 | 825 | 0.030 |
Why?
|
| Cytokines | 2 | 2011 | 7322 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 1341 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 853 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2001 | 2617 | 0.030 |
Why?
|
| Xanthine Oxidase | 1 | 1993 | 64 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2001 | 2902 | 0.030 |
Why?
|
| Catalase | 1 | 1993 | 222 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 1547 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2016 | 590 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2016 | 1100 | 0.030 |
Why?
|
| Binding Sites | 1 | 2020 | 6114 | 0.020 |
Why?
|
| Phylogeny | 2 | 1996 | 2803 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 4149 | 0.020 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2011 | 78 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2256 | 0.020 |
Why?
|
| Cholestasis | 1 | 1993 | 378 | 0.020 |
Why?
|
| Europe | 1 | 1997 | 3339 | 0.020 |
Why?
|
| Disease Progression | 1 | 2006 | 13284 | 0.020 |
Why?
|
| Animals | 8 | 2016 | 168757 | 0.020 |
Why?
|
| Superoxides | 1 | 1990 | 387 | 0.020 |
Why?
|
| HIV | 1 | 2016 | 1604 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1917 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 1997 | 10180 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6314 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6171 | 0.020 |
Why?
|
| Genes, rev | 1 | 2005 | 13 | 0.020 |
Why?
|
| Genes, vif | 1 | 2005 | 17 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9648 | 0.020 |
Why?
|
| Biological Therapy | 1 | 2005 | 138 | 0.010 |
Why?
|
| Lentivirus | 1 | 2005 | 501 | 0.010 |
Why?
|
| Female | 5 | 2016 | 380194 | 0.010 |
Why?
|
| DNA Probes | 1 | 2001 | 560 | 0.010 |
Why?
|
| World Health Organization | 2 | 1996 | 1318 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 2645 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 5892 | 0.010 |
Why?
|
| Mice | 2 | 2016 | 81183 | 0.010 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 1996 | 99 | 0.010 |
Why?
|
| Algorithms | 1 | 2016 | 13881 | 0.010 |
Why?
|
| Proviruses | 1 | 1997 | 318 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1994 | 156 | 0.010 |
Why?
|
| Viremia | 1 | 1997 | 736 | 0.010 |
Why?
|
| Male | 1 | 2012 | 350118 | 0.010 |
Why?
|
| Thailand | 1 | 1994 | 296 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 1333 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2005 | 2987 | 0.010 |
Why?
|
| Rwanda | 1 | 1994 | 703 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1996 | 1154 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2839 | 0.010 |
Why?
|
| Brazil | 1 | 1994 | 1270 | 0.010 |
Why?
|
| Uganda | 1 | 1994 | 1243 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1993 | 1901 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1993 | 2258 | 0.000 |
Why?
|
| Mutation | 1 | 2005 | 29786 | 0.000 |
Why?
|
| Genotype | 1 | 1994 | 12951 | 0.000 |
Why?
|
| Rats | 1 | 1993 | 24260 | 0.000 |
Why?
|
| Phenotype | 1 | 1994 | 16365 | 0.000 |
Why?
|
Concepts
(173)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_